查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1808870

無細胞胎兒DNA檢測市場（依產品類型、應用、最終用戶、國家及地區）－2025年至2032年全球產業分析、市場規模、市場佔有率及預測

Cell-free Fetal DNA Testing Market, By Product Type, By Application, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 389 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年無細胞胎兒 DNA 檢測市場規模價值 17.8923 億美元，2025 年至 2032 年的複合年成長率為 6.1%。

無細胞胎兒DNA (cffDNA) 檢測市場專注於非侵入性產前檢測 (NIPT)，即分析孕婦血液中循環的胎兒DNA小片段。此檢測有助於在妊娠早期檢測出唐氏症（21三體）、18三體和13三體等染色體異常，從而減少對羊膜穿刺術等風險較高的侵入性操作的需求。早期基因篩檢意識的增強、孕婦年齡的提高以及DNA定序技術的進步是推動市場發展的關鍵因素。

DNA 檢測因其安全性、準確性和早期檢測能力而日益受到醫療保健提供者的青睞。該市場正在全球擴張，尤其是在北美、歐洲和亞太部分地區。監管支持、個人化醫療的日益普及以及對胎兒性別檢測的需求也推動了其成長。然而，高昂的費用和低收入地區的醫療服務受限構成了挑戰。此檢測通常建議在妊娠 10 週後進行，並廣泛應用於高風險妊娠。市場涵蓋醫院、診斷實驗室和專科診所。

無細胞胎兒DNA檢測市場-市場動態

對雙胞胎和 IVF 妊娠的非侵入性檢測的需求不斷增加。

雙胞胎和體外受精 (IVF) 懷孕對非侵入性檢測的需求不斷成長，是遊離胎兒DNA (cffDNA) 檢測市場的利基促進因素。傳統的篩檢方法在多胎妊娠中往往準確度較低，因此 cffDNA 檢測成為更安全、更可靠的選擇。隨著輔助生殖技術 (ART) 的普及，全球雙胞胎和 IVF 的懷孕數量正在增加。這些懷孕通常被認為是高風險的，促使醫療保健提供者選擇 cffDNA 檢測等先進的篩檢工具。

這種方法能夠以更高的精確度區分單一胎兒和多個胎兒的DNA，這一點尤其重要。此外，有試管嬰兒（IVF）背景的準父母通常更積極主動地尋求早期準確的遺傳資訊。非侵入性檢測還能降低這些敏感妊娠中侵入性操作帶來的情緒和身體風險。技術進步提高了遊離DNA（cffDNA）檢測在複雜妊娠中的敏感度。這項利基需求正在推動遊離DNA檢測服務的更廣泛應用和發展。

無細胞胎兒DNA檢測市場—關鍵洞察

根據我們的研究分析師的分析，預計全球市場在預測期內（2025-2032 年）的年複合成長率約為 6.1%。

根據產品類型細分，預計三體檢測將在 2024 年佔據最大市場佔有率

根據應用細分，非整倍體篩檢是 2024 年的主要應用

從地區來看，北美是 2024 年最大的收入來源

無細胞胎兒 DNA 檢測市場-細分分析：

全球無細胞胎兒 DNA 檢測市場根據產品類型、應用、最終用戶和地區進行細分。

根據產品類型，市場分為四類：性別檢測、親子鑑定、三體性檢測和微缺失檢測。在「按檢測類型」細分市場中，三體性檢測在無細胞胎兒DNA檢測市場中佔據主導地位。此細分市場專注於識別染色體異常，例如21三體（唐氏症）、18三體症（愛德華茲症候群）和13三體（帕陶氏症候群），這些異常是妊娠期間檢測出的最常見且最嚴重的遺傳疾病。

早期、準確、非侵入性篩檢的臨床重要性及其需求推動了該領域佔據主導地位。三體症候群檢測被廣泛推薦用於高風險妊娠，並且在許多國家通常納入醫療保險範圍，進一步支持了其廣泛應用。 NGS技術的進步提高了檢測的靈敏度和特異性，使其成為可靠的選擇。隨著產前篩檢意識的不斷增強，該領域在全球檢測量和市場佔有率方面繼續保持領先地位。

根據應用，市場分為四類：非整倍體篩檢、胎兒性別鑑定和遺傳性疾病檢測。在「按應用」細分市場中，非整倍體篩檢在無細胞胎兒DNA檢測市場中佔據主導地位。非整倍體是指細胞中存在異常數量的染色體，這可能導致嚴重的遺傳性疾病，例如唐氏症、愛德華茲氏症候群和帕陶氏症候群。隨著孕婦年齡的成長和高齡妊娠中染色體異常風險的增加，對早期和準確篩檢的需求顯著增加。 cffDNA檢測是一種非侵入性、高靈敏度且特異的方法，最早可在妊娠第10週檢測出這些異常。

醫療保健提供者更傾向於這種篩檢，以避免羊膜穿刺術等侵入性操作帶來的併發症。此外，許多已開發地區的政府和保險公司支持非整倍體篩檢的報銷，從而提高了可近性。早期識別非整倍體對改善妊娠管理的臨床重要性，使該應用成為整體市場成長的關鍵驅動力。隨著技術的不斷進步和更廣泛的應用，預計該領域將在未來幾年保持領先地位。

無細胞胎兒DNA檢測市場—地理洞察

北美在遊離胎兒DNA (cffDNA) 檢測市場佔據領先地位，這得益於先進的醫療基礎設施、對產前篩檢的強烈認知以及非侵入性檢測技術的廣泛應用。美國憑藉較高的孕婦年齡、優惠的報銷政策以及 Natera、Labcorp 和 Illumina 等主要市場參與者的參與，在該區域市場佔據主導地位。此外，美國也受益於高風險懷孕率以及 cffDNA 檢測作為第一級篩檢方法的廣泛臨床接受度。

加拿大透過政府支持的產前計畫以及公立和私立醫療機構日益普及的基因檢測，做出了巨大貢獻。兩國新一代定序平台的推出和支援性監管框架的完善，進一步推動了這一成長。此外，患者對早期胎兒健康洞察的偏好日益成長，以及個人化醫療的興起，也持續擴大了市場規模。北美在遊離DNA（cffDNA）檢測領域的創新、研究和商業化方面依然處於領先地位。

無細胞胎兒 DNA 檢測市場 - 競爭格局：

無細胞胎兒DNA (cffDNA) 檢測市場的競爭格局以創新驅動策略為標誌，主要參與者專注於提升檢測準確性、全球覆蓋範圍和臨床應用。 Illumina、Natera、Roche 和 Labcorp 等公司以專有技術和經過驗證的檢測產品引領市場。檢測靈敏度競爭激烈，尤其是在雙胞胎和試管受精等複雜懷孕情況下。為提升服務的可近性，與醫院和診斷實驗室建立策略合作夥伴關係、進行收購和合作已成為常態。許多參與者正在投資人工智慧資料分析，以提升對基因的洞察。

華大基因等亞太地區的區域企業也憑藉著具成本效益的產品獲得了關注。法規核准和報銷政策進一步塑造了市場動態。直接面對消費者的基因檢測的興起，促使一些公司開發了患者友善平台。整體而言，市場呈現全球巨頭與敏捷新創公司交織的局面，它們透過創新、臨床可靠性和市場滲透力競爭。

最新動態：

2025年1月，Ravgen公司在美國聯邦巡迴法院贏得了一項關鍵裁決，該裁決駁回了其對Labcorp公司提起的長期專利侵權訴訟。法院的判決有利於Ravgen公司，可能導致其獲得超過4億美元的賠償，這凸顯了非侵入性產前檢測市場中智慧財產權的高風險性。

目錄

第1章：無細胞胎兒DNA檢測市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • 無細胞胎兒 DNA 檢測市場（依產品類型）
    • 無細胞胎兒 DNA 檢測市場片段（依應用）
    • 無細胞胎兒 DNA 檢測市場（依最終用戶）
    • 無細胞胎兒DNA檢測市場（按國家/地區）
    • 無細胞胎兒DNA檢測市場（按地區）
  • 競爭洞察

第3章：無細胞胎兒DNA檢測主要市場趨勢

  • 無細胞胎兒DNA檢測市場促進因素
    • 市場促進因素的影響分析
  • 無細胞胎兒DNA檢測市場限制
    • 市場限制的影響分析
  • 無細胞胎兒DNA檢測市場機會
  • 無細胞胎兒DNA檢測市場未來趨勢

第4章：無細胞胎兒DNA檢測產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：無細胞胎兒DNA檢測市場：地緣政治緊張局勢升級的影響

  • COVID-19 疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：無細胞胎兒DNA檢測市場格局

  • 2024年無細胞胎兒DNA檢測市佔率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：無細胞胎兒DNA檢測市場－依產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 性別測試
    • 親子鑑定
    • 三體性檢測
    • 微缺失檢測

第 8 章：無細胞胎兒 DNA 檢測市場 - 按應用

  • 概述
    • 按應用細分市場佔有率分析
    • 非整倍體篩檢
    • 胎兒性別鑑定
    • 遺傳疾病檢測

第9章：無細胞胎兒DNA檢測市場－依最終用戶

  • 概述
    • 按最終用戶細分的佔有率分析
    • 醫院
    • 診斷實驗室
    • 產科診所
    • 研究中心

第 10 章：無細胞胎兒 DNA 檢測市場 - 按地區分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美無細胞胎兒DNA檢測主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模及預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲無細胞胎兒DNA檢測主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模和預測，按應用
    • 歐洲市場規模及預測（按最終用戶）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區胎兒無細胞DNA檢測主要製造商
    • 亞太地區市場規模及預測（依國家）
    • 亞太地區市場規模及預測（依產品類型）
    • 亞太地區市場規模及預測（按應用）
    • 亞太地區市場規模及預測（依最終用戶）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲無細胞胎兒DNA檢測主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（依產品類型）
    • 拉丁美洲市場規模及預測（按應用）
    • 拉丁美洲市場規模及預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲的無細胞胎兒DNA檢測主要製造商
    • MEA 市場規模及預測（依國家/地區）
    • MEA 市場規模及預測（依產品類型）
    • MEA 市場規模及預測（按應用）
    • MEA 市場規模及預測（依最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 11 章：主要供應商分析-無細胞胎兒 DNA 檢測產業

  • 競爭儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Illumina, Inc.
    • Natera, Inc.
    • Laboratory Corporation of America Holdings (Labcorp)
    • F. Hoffmann-La Roche Ltd
    • Quest Diagnostics Incorporated
    • BGI Genomics Co., Ltd.
    • Eurofins Scientific
    • Myriad Genetics, Inc.
    • Thermo Fisher Scientific Inc.
    • PerkinElmer, Inc.
    • Agilent Technologies, Inc.
    • Centogene NV
    • GE Healthcare
    • MedGenome Labs Ltd.
    • Yourgene Health
    • Genetron Holdings Limited
    • Progenity, Inc.
    • Invitae Corporation
    • Ariosa Diagnostics (a Roche company)
    • Bio-Rad Laboratories, Inc

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5534

Cell-free Fetal DNA Testing Market size was valued at US$ 1,789.23 Million in 2024, expanding at a CAGR of 6.1% from 2025 to 2032.

The Cell-free Fetal DNA (cffDNA) Testing market focuses on non-invasive prenatal testing (NIPT) that analyzes small fragments of fetal DNA circulating in a pregnant woman's blood. This test helps detect chromosomal abnormalities such as Down syndrome (trisomy 21), trisomy 18, and trisomy 13 early in pregnancy, reducing the need for riskier invasive procedures like amniocentesis. The growing awareness about early genetic screening, rising maternal age, and advancements in DNA sequencing technology are key market drivers.

Healthcare providers increasingly prefer DNA testing due to its safety, accuracy, and early detection capabilities. The market is expanding globally, particularly in North America, Europe, and parts of Asia-Pacific. Regulatory support, increasing adoption of personalized medicine, and demand for fetal gender testing also contribute to its growth. However, high costs and limited access in low-income regions pose challenges. The test is typically recommended after 10 weeks of gestation and is widely used in high-risk pregnancies. The market encompasses hospitals, diagnostic labs, and specialty clinics.

Cell-free Fetal DNA Testing Market- Market Dynamics

Rising demand for non-invasive testing in twin and IVF pregnancies.

A niche driver for the Cell-free Fetal DNA (cffDNA) Testing market is the rising demand for non-invasive testing in twin and in vitro fertilization (IVF) pregnancies. Traditional screening methods often show reduced accuracy in multiple pregnancies, making cffDNA testing a safer and more reliable option. With the increasing use of assisted reproductive technologies (ART), the number of twin and IVF pregnancies is growing globally. These pregnancies are generally considered high-risk, prompting healthcare providers to opt for advanced screening tools like cffDNA testing.

The ability of this method to differentiate fetal DNA from multiple fetuses with higher precision is particularly valuable. Moreover, expectant parents from IVF backgrounds are often more proactive in seeking early and accurate genetic information. Non-invasive tests also reduce the emotional and physical risks associated with invasive procedures in these sensitive pregnancies. Technological advancements have improved the sensitivity of cffDNA tests in complex pregnancies. This niche demand is contributing to the broader adoption and development of cffDNA testing services.

Cell-free Fetal DNA Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.1% over the forecast period (2025-2032)

Based on product type segmentation, Trisomy Detection was predicted to show maximum market share in the year 2024

Based on application segmentation, Aneuploidy Screening was the leading application in 2024

Based on region, North America was the leading revenue generator in 2024

Cell-free Fetal DNA Testing Market- Segmentation Analysis:

The Global Cell-free Fetal DNA Testing Market is segmented on the basis of Product Type, Application, End-user, and Region.

The market is divided into four categories based on product type: Gender Testing, Paternity Testing, Trisomy Detection, and Microdeletion Testing. Within the "By Test Type" segment, Trisomy Detection is the most dominant in the Cell-free Fetal DNA Testing market. This segment focuses on identifying chromosomal abnormalities such as Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), and Trisomy 13 (Patau syndrome), which are among the most common and serious genetic conditions detected during pregnancy.

The high clinical importance and demand for early, accurate, and non-invasive screening drive the dominance of this segment. Trisomy detection is widely recommended for high-risk pregnancies and is often covered by insurance in many countries, further supporting its widespread use. Technological advancements in NGS have improved detection sensitivity and specificity, making it a reliable choice. As awareness of prenatal screening grows, this segment continues to lead in test volume and market share globally.

The market is divided into four categories based on application: Aneuploidy Screening, Fetal Sex Determination, and Genetic Disorder Detection. Among the "By Application" segments, Aneuploidy Screening is the most dominant in the Cell-free Fetal DNA Testing market. Aneuploidy refers to the presence of an abnormal number of chromosomes in a cell, which can lead to serious genetic disorders such as Down syndrome, Edwards syndrome, and Patau syndrome. The increasing maternal age and higher risk of chromosomal abnormalities in older pregnancies have significantly driven the demand for early and accurate screening. cffDNA testing offers a non-invasive, highly sensitive, and specific method to detect these abnormalities as early as the 10th week of gestation.

Healthcare providers prefer this screening to avoid the complications associated with invasive procedures like amniocentesis. Additionally, governments and insurance companies in many developed regions support reimbursement for aneuploidy screening, enhancing accessibility. The clinical importance of identifying aneuploidies early for better pregnancy management has positioned this application as the key driver of overall market growth. With ongoing technological advancements and broader adoption, this segment is expected to maintain its lead in the coming years.

Cell-free Fetal DNA Testing Market- Geographical Insights

North America holds a leading position in the Cell-free Fetal DNA (cffDNA) Testing market, driven by advanced healthcare infrastructure, strong awareness about prenatal screening, and widespread adoption of non-invasive testing technologies. The United States dominates the regional market due to high maternal age, favorable reimbursement policies, and the presence of major market players like Natera, Labcorp, and Illumina. The U.S. also benefits from a high rate of high-risk pregnancies and broad clinical acceptance of cffDNA tests as a first-tier screening method.

Canada contributes significantly through government-backed prenatal programs and increasing use of genetic testing in both public and private healthcare sectors. The availability of next-generation sequencing platforms and supportive regulatory frameworks in both countries has further fueled growth. In addition, rising patient preference for early fetal health insights and the shift toward personalized medicine continue to expand the market. North America remains at the forefront of innovation, research, and commercialization in the cffDNA testing space.

Cell-free Fetal DNA Testing Market- Competitive Landscape:

The competitive landscape of the Cell-free Fetal DNA (cffDNA) Testing market is marked by innovation-driven strategies, with key players focusing on expanding test accuracy, global reach, and clinical applications. Companies like Illumina, Natera, Roche, and Labcorp lead the market with proprietary technologies and validated test offerings. Intense competition exists in test sensitivity, especially for complex pregnancies such as twins and IVF cases. Strategic partnerships, acquisitions, and collaborations with hospitals and diagnostic labs are common to enhance service accessibility. Many players are investing in AI-powered data analysis to improve genetic insights.

Regional players in Asia-Pacific, such as BGI Genomics, are also gaining traction through cost-effective offerings. Regulatory approvals and reimbursement policies further shape market dynamics. The rise in direct-to-consumer genetic testing has led some firms to develop patient-friendly platforms. Overall, the market reflects a blend of global giants and agile startups competing through innovation, clinical reliability, and market penetration.

Recent Developments:

In January 2025, Ravgen won a key ruling at the U.S. Federal Circuit in its long-standing patent infringement case against Labcorp. The court's decision, favoring Ravgen, may result in an award of damages exceeding $400 million, highlighting the high-stakes nature of intellectual property within the non-invasive prenatal testing market

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CELL-FREE FETAL DNA TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Illumina, Inc.
  • Natera, Inc.
  • Laboratory Corporation of America Holdings (Labcorp)
  • F. Hoffmann-La Roche Ltd
  • Quest Diagnostics Incorporated
  • BGI Genomics Co., Ltd.
  • Eurofins Scientific
  • Myriad Genetics, Inc.
  • Thermo Fisher Scientific Inc.
  • PerkinElmer, Inc.
  • Agilent Technologies, Inc.
  • Centogene N.V.
  • GE Healthcare
  • MedGenome Labs Ltd.
  • Yourgene Health
  • Genetron Holdings Limited
  • Progenity, Inc.
  • Invitae Corporation
  • Ariosa Diagnostics (a Roche company)
  • Bio-Rad Laboratories, Inc.

GLOBAL CELL-FREE FETAL DNA TESTING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Gender Testing
  • Paternity Testing
  • Trisomy Detection
  • Microdeletion Testing

GLOBAL CELL-FREE FETAL DNA TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Aneuploidy Screening
  • Fetal Sex Determination
  • Genetic Disorder Detection

GLOBAL CELL-FREE FETAL DNA TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Laboratories
  • Maternity Clinics
  • Research Centers

GLOBAL CELL-FREE FETAL DNA TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cell-free Fetal DNA Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cell-free Fetal DNA Testing Market Snippet by Product Type
    • 2.1.2. Cell-free Fetal DNA Testing Market Snippet by Application
    • 2.1.3. Cell-free Fetal DNA Testing Market Snippet by End-user
    • 2.1.4. Cell-free Fetal DNA Testing Market Snippet by Country
    • 2.1.5. Cell-free Fetal DNA Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Cell-free Fetal DNA Testing Key Market Trends

  • 3.1. Cell-free Fetal DNA Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cell-free Fetal DNA Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cell-free Fetal DNA Testing Market Opportunities
  • 3.4. Cell-free Fetal DNA Testing Market Future Trends

4. Cell-free Fetal DNA Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cell-free Fetal DNA Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Cell-free Fetal DNA Testing Market Landscape

  • 6.1. Cell-free Fetal DNA Testing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cell-free Fetal DNA Testing Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Gender Testing
    • 7.1.3. Paternity Testing
    • 7.1.4. Trisomy Detection
    • 7.1.5. Microdeletion Testing

8. Cell-free Fetal DNA Testing Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Aneuploidy Screening
    • 8.1.3. Fetal Sex Determination
    • 8.1.4. Genetic Disorder Detection

9. Cell-free Fetal DNA Testing Market - By End-user

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Diagnostic Laboratories
    • 9.1.4. Maternity Clinics
    • 9.1.5. Research Centers

10. Cell-free Fetal DNA Testing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Cell-free Fetal DNA Testing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Cell-free Fetal DNA Testing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Cell-free Fetal DNA Testing Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Cell-free Fetal DNA Testing Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Cell-free Fetal DNA Testing Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Cell-free Fetal DNA Testing Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Illumina, Inc.
    • 11.2.2. Natera, Inc.
    • 11.2.3. Laboratory Corporation of America Holdings (Labcorp)
    • 11.2.4. F. Hoffmann-La Roche Ltd
    • 11.2.5. Quest Diagnostics Incorporated
    • 11.2.6. BGI Genomics Co., Ltd.
    • 11.2.7. Eurofins Scientific
    • 11.2.8. Myriad Genetics, Inc.
    • 11.2.9. Thermo Fisher Scientific Inc.
    • 11.2.10. PerkinElmer, Inc.
    • 11.2.11. Agilent Technologies, Inc.
    • 11.2.12. Centogene N.V.
    • 11.2.13. GE Healthcare
    • 11.2.14. MedGenome Labs Ltd.
    • 11.2.15. Yourgene Health
    • 11.2.16. Genetron Holdings Limited
    • 11.2.17. Progenity, Inc.
    • 11.2.18. Invitae Corporation
    • 11.2.19. Ariosa Diagnostics (a Roche company)
    • 11.2.20. Bio-Rad Laboratories, Inc

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us